Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study

Background and Aims. The secretion of several adipocytokines, such as adiponectin, retinol-binding protein 4 (RBP4), adipocyte fatty acid binding protein (aFABP), and visfatin, is altered in subjects with abdominal adiposity; these endocrine alterations could contribute to increased cardiovascular r...

Full description

Saved in:
Bibliographic Details
Main Authors: Laura Pala, Matteo Monami, Silvia Ciani, Ilaria Dicembrini, Alessandro Pasqua, Anna Pezzatini, Paolo Francesconi, Barbara Cresci, Edoardo Mannucci, Carlo Maria Rotella
Format: Article
Language:English
Published: Wiley 2012-01-01
Series:Journal of Nutrition and Metabolism
Online Access:http://dx.doi.org/10.1155/2012/253428
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849305286281527296
author Laura Pala
Matteo Monami
Silvia Ciani
Ilaria Dicembrini
Alessandro Pasqua
Anna Pezzatini
Paolo Francesconi
Barbara Cresci
Edoardo Mannucci
Carlo Maria Rotella
author_facet Laura Pala
Matteo Monami
Silvia Ciani
Ilaria Dicembrini
Alessandro Pasqua
Anna Pezzatini
Paolo Francesconi
Barbara Cresci
Edoardo Mannucci
Carlo Maria Rotella
author_sort Laura Pala
collection DOAJ
description Background and Aims. The secretion of several adipocytokines, such as adiponectin, retinol-binding protein 4 (RBP4), adipocyte fatty acid binding protein (aFABP), and visfatin, is altered in subjects with abdominal adiposity; these endocrine alterations could contribute to increased cardiovascular risk. The aim of the study was to assess the relationship among adiponectin, RBP4, aFABP, and visfatin, and incident cardiovascular disease. Methods and Results. A case-control study, nested within a prospective cohort, on 2945 subjects enrolled for a diabetes screening program was performed. We studied 18 patients with incident fatal or nonfatal IHD (Ischemic Heart Disease) or CVD (Cerebrovascular Disease), compared with 18 matched control subjects. Circulating adiponectin levels were significantly lower in cases of IHD with respect to controls. Circulating RBP4 levels were significantly increased in CVD and decreased in IHD with respect to controls. Circulating aFABP4 levels were significantly increased in CVD, while no difference was associated with IHD. Circulating visfatin levels were significantly lower in cases of both CVD and IHD with respect to controls, while no difference was associated with CVD. Conclusions. The present study confirms that low adiponectin is associated with increased incidents of IHD, but not CVD, and suggests, for the first time, a major effect of visfatin, aFABP, and RBP4 in the development of cardiovascular disease.
format Article
id doaj-art-07cfe85ecbed4714b87f4c92663fa2c2
institution Kabale University
issn 2090-0724
2090-0732
language English
publishDate 2012-01-01
publisher Wiley
record_format Article
series Journal of Nutrition and Metabolism
spelling doaj-art-07cfe85ecbed4714b87f4c92663fa2c22025-08-20T03:55:28ZengWileyJournal of Nutrition and Metabolism2090-07242090-07322012-01-01201210.1155/2012/253428253428Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control StudyLaura Pala0Matteo Monami1Silvia Ciani2Ilaria Dicembrini3Alessandro Pasqua4Anna Pezzatini5Paolo Francesconi6Barbara Cresci7Edoardo Mannucci8Carlo Maria Rotella9SOD of Endocrinology, AOUC, 50139 Florence, ItalyUnit of Gerontology and Geriatrics, Department of Critical Care Medicine and Surgery, University of Florence, 50139 Florence, ItalySection of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Viale P ieraccini 6, 50139 Florence, ItalySection of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Viale P ieraccini 6, 50139 Florence, ItalyEpidemiology Unit, Local Health Unit 10, Florence, ItalySection of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Viale P ieraccini 6, 50139 Florence, ItalyEpidemiology Unit, Local Health Unit 10, Florence, ItalySOD of Endocrinology, AOUC, 50139 Florence, ItalyDiabetic Agency, AOUC, 50139 Florence, ItalySection of Endocrinology, Department of Clinical Pathophysiology, University of Florence, Viale P ieraccini 6, 50139 Florence, ItalyBackground and Aims. The secretion of several adipocytokines, such as adiponectin, retinol-binding protein 4 (RBP4), adipocyte fatty acid binding protein (aFABP), and visfatin, is altered in subjects with abdominal adiposity; these endocrine alterations could contribute to increased cardiovascular risk. The aim of the study was to assess the relationship among adiponectin, RBP4, aFABP, and visfatin, and incident cardiovascular disease. Methods and Results. A case-control study, nested within a prospective cohort, on 2945 subjects enrolled for a diabetes screening program was performed. We studied 18 patients with incident fatal or nonfatal IHD (Ischemic Heart Disease) or CVD (Cerebrovascular Disease), compared with 18 matched control subjects. Circulating adiponectin levels were significantly lower in cases of IHD with respect to controls. Circulating RBP4 levels were significantly increased in CVD and decreased in IHD with respect to controls. Circulating aFABP4 levels were significantly increased in CVD, while no difference was associated with IHD. Circulating visfatin levels were significantly lower in cases of both CVD and IHD with respect to controls, while no difference was associated with CVD. Conclusions. The present study confirms that low adiponectin is associated with increased incidents of IHD, but not CVD, and suggests, for the first time, a major effect of visfatin, aFABP, and RBP4 in the development of cardiovascular disease.http://dx.doi.org/10.1155/2012/253428
spellingShingle Laura Pala
Matteo Monami
Silvia Ciani
Ilaria Dicembrini
Alessandro Pasqua
Anna Pezzatini
Paolo Francesconi
Barbara Cresci
Edoardo Mannucci
Carlo Maria Rotella
Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study
Journal of Nutrition and Metabolism
title Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study
title_full Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study
title_fullStr Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study
title_full_unstemmed Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study
title_short Adipokines as Possible New Predictors of Cardiovascular Diseases: A Case Control Study
title_sort adipokines as possible new predictors of cardiovascular diseases a case control study
url http://dx.doi.org/10.1155/2012/253428
work_keys_str_mv AT laurapala adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT matteomonami adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT silviaciani adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT ilariadicembrini adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT alessandropasqua adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT annapezzatini adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT paolofrancesconi adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT barbaracresci adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT edoardomannucci adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy
AT carlomariarotella adipokinesaspossiblenewpredictorsofcardiovasculardiseasesacasecontrolstudy